Sourasky Medical Center (Ichilov)
Sourasky Medical Center (Ichilov)
Israël, Tel Aviv
Ofer Merimsky
41 années d'expérience
accréditations :
La clinique est certifiée :
Pourquoi choisir Israël pour la radiothérapie du cancer du poumon ?
Accédez à des solutions avancées de radiothérapie pour le cancer du poumon dans des cliniques de confiance .
Jour 1
Jour 2
Jour 3
Jour 4 au jour 20
Jour 21
Jour 22
Semaine 1 à semaine 6 post-opératoire
À partir de la semaine 6
Veuillez noter que le processus de rétablissement de chaque patient peut varier en fonction des circonstances individuelles et de l'état de santé général.
Chef de l'Unité d'oncologie des tissus mous et des os au Centre médical Sourasky – Le Prof. Merimsky est spécialisé dans les cas complexes de cancer du poumon.
Le Dr Ari Raphael est un expert de premier plan en radiothérapie du cancer du poumon, avec un accent particulier sur le profilage génomique avancé et les essais cliniques.
Dr. Yaacov Lawrence, MA, MBBS, MRCP, is Chair of Radiation Oncology at Sheba Medical Center. He has nearly 30 years of experience in precision radiation oncology and neuro-oncology.
He is an expert in advanced radiation therapy and radiosurgery. He performs stereotactic radiosurgery for brain tumors. He leads Sheba’s GI Cancer Program in gastrointestinal oncology. He also provides precision care for lung and prostate cancers. He pioneered celiac plexus radiosurgery for severe pain from pancreatic cancer.
Training and credentials: MA and MBBS (Cambridge and UCLH); MRCP (RCP); Radiation Oncology fellowship (Thomas Jefferson University). Honors include the ASCO Young Investigator Award and Fellow of ASTRO (FASTRO). He has authored over 280 publications. He is Director of the Center for Translational Radiation Oncology and an Associate Professor at Tel Aviv University.
Professor Jair Bar, MD, PhD, is a thoracic oncologist and Deputy Director of the Cancer Center at Sheba Medical Center. He leads the Thoracic Oncology Unit. He treats lung cancer, including advanced non-small cell cases. His care includes medical oncology, radiotherapy, immunotherapy, and targeted therapy.
He runs a translational research lab focused on resistance to immunotherapy. He has published on exhaled-breath cancer metabolism and on angiogenesis inhibition in lung cancer.
He has chaired the Israel Lung Cancer Group since 2003. He is a member of the Israel Society of Clinical Oncology and Radiotherapy, the American Society of Clinical Oncology, and the American Association for Cancer Research. He is board-certified in Medical Oncology and Radiotherapy Oncology. He is a Senior Lecturer at Tel Aviv University.